ClinVar Miner

Submissions for variant NM_000038.6(APC):c.532-2A>C

dbSNP: rs752152148
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV003537308 SCV000965309 pathogenic Familial adenomatous polyposis 1 2019-03-13 criteria provided, single submitter clinical testing Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). For these reasons, this variant has been classified as Pathogenic. Experimental studies using mRNA extracted from peripheral blood cells of an affected individual have shown that this variant results in aberrant splicing (PMID: 10083733). This variant has been observed in an individual affected with familial adenomatous polyposis (PMID: 10083733). This variant is described as an ag/TT -> cg/TT change at the splice acceptor site of exon5 in the literature. This variant is not present in population databases (ExAC no frequency). This sequence change affects an acceptor splice site in intron 5 of the APC gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.